← All programs
RetatrutideSemaglutideTirzepatideTesamorelin

Weight.

The Weight program covers the incretin-based compounds behind the biggest advances in metabolic medicine. On the physician pathway, an independent physician reviews your health profile and goals and gives an opinion on whether a protocol is suitable for you.

Eligibility

These compounds are not suitable for everyone. Do not use them if you are pregnant, planning a pregnancy or breastfeeding, or if you have a personal or family history of medullary thyroid cancer or MEN2, a history of pancreatitis, or significant gastrointestinal disease. Consulting with your physician is strongly recommended.

Outcomes

Benefits you can feel.

Appetite regulation
metabolic health and body composition
Science

The science behind it.

Modern weight management compounds act on incretin and metabolic pathways — including GLP-1, GIP, and glucagon receptors — to support appetite regulation, insulin sensitivity, and body composition. Their effects are best established in adults with obesity or type 2 diabetes.

Compounds

Explore each compound.

Detailed reference for the compounds your physician may prescribe within this program.

Retatrutide

What it is
A next-generation triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. The most advanced weight management compound currently in clinical development.
What it does
Produces significantly greater weight loss than dual or single receptor agonists. Phase 2 trials demonstrated up to 24% body weight reduction. Reduces appetite, improves metabolic rate, and addresses visceral fat accumulation. Glucagon receptor activity adds metabolic burn beyond GLP-1 alone.
Who it is for
Patients with significant weight management goals, metabolic syndrome, or those who have not achieved sufficient results with GLP-1 monotherapy. Physician assessment of suitability is mandatory.
Format
Lyophilised vial — subcutaneous injection. Weekly administration.
Programme cycle
16-week minimum protocol with titration schedule. Physician review every 4 weeks.

Start with a consult

$99one-time

One-time telehealth consultation. Your physician will review your intake and determine whether a protocol is appropriate. Program is priced separately only if prescribed.